Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA5A | P35218 | 2/20 | 0.50 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.50 |
| ▸ | BLM | P54132 | 4/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | SLC6A6 | P31641 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 5/20 | 0.43 |
| ▸ | CA2 | P00918 | 4/20 | 0.43 |
| ▸ | TSHR | P16473 | 3/20 | 0.43 |
| ▸ | NT5E | P21589 | 1/20 | 0.43 |
| ▸ | CA4 | P22748 | 1/20 | 0.43 |
| ▸ | CA6 | P23280 | 1/20 | 0.43 |
| ▸ | CA7 | P43166 | 1/20 | 0.43 |
| ▸ | CA9 | Q16790 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.40 |
| ▸ | APP | P05067 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid SCHEMBL3677190 | 1.00 | CA5A (0.50) | CA5ACA5BBLMCYP2C19LMNA | |
| Sulfuric Acid SCHEMBL921788 | 1.00 | — | — | |
| Sulfuric Acid SCHEMBL28919815 | 0.96 | — | — | |
| Sulfuric Acid SCHEMBL6509471 | 0.96 | CA5A (0.46) | CA5ACA5BBLMCYP2C19LMNA | |
| Sulfuric Acid SCHEMBL28158068 | 0.96 | — | — | |
| Sulfuric Acid SCHEMBL28521927 | 0.89 | CA5A (0.40) | CA5ACA5BBLMCYP2C19LMNA | |
| Ethylamine SCHEMBL9647576 | 0.88 | — | — | |
| Sulfamate SCHEMBL18543083 | 0.88 | — | — | |
| Ethylamine SCHEMBL6138422 | 0.88 | — | — | |
| Sulfuric Acid SCHEMBL23354592 | 0.87 | TP53 (0.46) | CA5ACA5BBLMCYP2C19LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107004912-A | Electrolyte and metal hydride battery | 巴斯夫公司 | 2017-08-01 | — | — | CN | claimed |
| CN-110256418-A | The benzamide that 1,3- thiazol-2-yl replaces | 拜耳公司 | 2019-09-20 | — | — | CN | disclosed |
| CN-107004912-A | Electrolyte and metal hydride battery | 巴斯夫公司 | 2017-08-01 | — | — | CN | disclosed |
| CN-106715418-A | Therapeutic compounds and methods of use thereof | 基因泰克公司 | 2017-05-24 | — | — | CN | disclosed |
| CN-105793238-A | Substituted benzamides and methods of use thereof | 基因泰克公司 | 2016-07-20 | — | — | CN | disclosed |
| CN-102056671-B | Materials and methods for enhanced selective separations | GEORGIA PACIFIC CHEMICALS LLC | 2014-01-29 | — | — | CN | disclosed |
| CN-102056671-A | Materials and methods for enhanced selective separations | GEORGIA PACIFIC CHEMICALS LLC | 2011-05-11 | — | — | CN | disclosed |
| CN-100566761-C | The absorbent that comprises the water-swellable material that has applied | PROCTER & GAMBLE (US) | 2009-12-09 | — | — | CN | disclosed |
| CN-100471525-C | Absorbent article comprising coated water-swellable material | PROCTER & GAMBLE (US) | 2009-03-25 | — | — | CN | disclosed |
| CN-100471524-C | Process for producing water-swellable material comprising coated water-swellable polymers | PROCTER & GAMBLE (US) | 2009-03-25 | — | — | CN | disclosed |
| CN-1832767-A | Process for producing water-swellable material comprising coated water-swellable polymers | PROCTER & GAMBLE (US) | 2006-09-13 | — | — | CN | disclosed |
| CN-1832769-A | Absorbent article comprising coated water swellable material | PROCTER & GAMBLE (US) | 2006-09-13 | — | — | CN | disclosed |
| CN-1832768-A | Process for making water-swellable material comprising coated water-swellable polymers | PROCTER & GAMBLE (US) | 2006-09-13 | — | — | CN | disclosed |
| CN-1832771-A | Process for making surface treated absorbent gelling material | PROCTER & GAMBLE (US) | 2006-09-13 | — | — | CN | disclosed |
| CN-1832766-A | Absorbent structure comprising coated water-swellable material | PROCTER & GAMBLE (US) | 2006-09-13 | — | — | CN | disclosed |
| CN-1832770-A | Absorbent article comprising coated water swellable material | PROCTER & GAMBLE (US) | 2006-09-13 | — | — | CN | disclosed |
| CN-1052977-C | Method for preparing moclobemide | SHANGHAI PHARMACEUTICAL INDUST (CN) | 2000-05-31 | — | — | CN | disclosed |
| CN-1160047-A | Method for preparing moclobemide | SHANGHAI PHARMACEUTICAL INDUST (CN) | 1997-09-24 | — | — | CN | disclosed |
| EP-0565863-B1 | Semi-synthetic glycosaminoglycans with heparin or heparan structure of alpha-L-iduronic-2-0-sulfate acid modified in position 2 | ALFA WASSERMANN SPA (IT) | 1997-06-18 | — | — | EP | disclosed |
| EP-0565863-A2 | Semi-synthetic glycosaminoglycans with heparin or heparan structure of alpha-L-iduronic-2-0-sulfate acid modified in position 2 | ALFA WASSERMANN S.p.A. (IT) | 1993-10-20 | — | — | EP | disclosed |